Barbara Troupin
CIK 1627886 · Chief Medical Officer · last filed 2026-05-29
Barbara Troupin is a Chief Medical Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for EQ, was dated May 29, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EQ | Director | — | $2.81 | — | $0 | 6 | 2026-05-29 |
| Neurogene Inc. (AQXP) Delisted | Chief Medical Officer | — | — | — | $0 | 3 | 2018-03-13 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | SVP, Chief Medical Officer | 43,918 | — | — | $0 | 3 | 2016-03-17 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | EQ | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | EQ | Mixed | — | $0 | EDGAR |
| 2024-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2023-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2022-03-08 | EQ | Grant (A) | — | $0 | EDGAR |
| 2018-03-13 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-10 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-10 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-17 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +43,918 | $0 | EDGAR |